Growth Metrics

Soleno Therapeutics (SLNO) Short term Debt: 2013-2015

Historic Short term Debt for Soleno Therapeutics (SLNO) over the last 1 years, with Dec 2015 value amounting to $865,000.

  • Soleno Therapeutics' Short term Debt rose 751.97% to $865,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $865,000, marking a year-over-year increase of 751.97%. This contributed to the annual value of $865,000 for FY2015, which is 751.97% up from last year.
  • According to the latest figures from Q4 2015, Soleno Therapeutics' Short term Debt is $865,000, which was down 77.54% from $3.9 million recorded in Q3 2015.
  • Soleno Therapeutics' Short term Debt's 5-year high stood at $14.0 million during Q4 2013, with a 5-year trough of $101,529 in Q4 2014.
  • Its 3-year average for Short term Debt is $6.0 million, with a median of $3.9 million in 2015.
  • Its Short term Debt has fluctuated over the past 5 years, first plummeted by 99.27% in 2014, then spiked by 751.97% in 2015.
  • Soleno Therapeutics' Short term Debt (Quarterly) stood at $14.0 million in 2013, then plummeted by 99.27% to $101,529 in 2014, then soared by 751.97% to $865,000 in 2015.
  • Its Short term Debt stands at $865,000 for Q4 2015, versus $3.9 million for Q3 2015 and $11.0 million for Q2 2015.